Patents-Review.com
ClassID:

97260 ⎘

C07K2317/22 - page 2 - CPC Classification

Classification description:

Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary

Recent Application in this class:
#301
20210238247
2021-08-05

TARGETING OF HUMAN INTERFERON ANTAGONISTS

 #302
20210230629
2021-07-29

Camelization of a human variable domain by gene conversion

 #303
20210230291
2021-07-29

TARGETED ENGINEERED INTERFERON AND USES THEREOF

 #304
20210227810
2021-07-29

PRODUCTION OF ANTIBODIES BY MODIFICATION OF AN AUTONOMOUS HEAVY CHAIN VARIABLE DOMAIN BY GENE CONVERSION

 #305
20210221891
2021-07-22

Single-domain antibodies and variants thereof against PD-L1

 #306
20210206842
2021-07-08

Antibodies and antibody fragments against HNAV1.7 channel and their use in pain and cancer indications

 #307
20210198646
2021-07-01

Methods to create chemically-induced dimerizing protein systems for regulation of cellular events

 #308
20210188967
2021-06-24

Nucleic acids encoding polypeptides against IL-23

 #309
20210171649
2021-06-10

B cell maturation antigen binding proteins

 #310
20210171613
2021-06-10

CLOSTRIDIUM DIFFICILE-SPECIFIC ANTIBODIES AND USES THEREOF

 #311
20210163615
2021-06-03

Chimeric antigen receptors targeting BCMA and methods of use thereof

 #312
20210162010
2021-06-03

TARGETED HUMAN-INTERFERON FUSION PROTEINS

 #313
20210139587
2021-05-13

Amino acid sequences that modulate the interaction between cells of the immune system

 #314
20210130452
2021-05-06

Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same

 #315
20210115117
2021-04-22

Aggrecan binding immunoglobulins

 #316
20210113702
2021-04-22

Methods of treating an ocular disease or disorder

 #317
20210087279
2021-03-25

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

 #318
20210087265
2021-03-25

Compositions and methods for detecting and treating prostate cancer using progastrin binding molecule

 #319
20210087261
2021-03-25

Immunoglobulin variable domains

 #320
20210085785
2021-03-25

TREATING CANCER BY BLOCKING THE INTERACTION OF VISTA AND ITS BINDING PARTNER

 #321
20210085784
2021-03-25

Compositions and methods for treating lung cancer

 #322
20210079385
2021-03-18

METHOD OF ACQUIRING OR SPECIFYING ANTIBODY THAT RECOGNIZES TARGET SUBSTANCE AND ANTIBODY

 #323
20210054071
2021-02-25

Single-domain antibodies and variants thereof against TIGIT

 #324
20210046114
2021-02-18

HPV IMMUNOTHERAPY

 #325
20210040187
2021-02-11

Nanobodies suitable for neuron regeneration therapy

 #326
20210024639
2021-01-28

METHODS FOR PROMOTING PANCREATIC ISLET CELL GROWTH

 #327
20200399382
2020-12-24

Multispecific antibodies against IL-5 and IL-4R

 #328
20200354424
2020-11-12

XCR1 BINDING AGENTS AND USES THEREOF

 #329
20200347135
2020-11-05

Single-domain antibodies and variants thereof against PD-1

 #330
20200339676
2020-10-29

Compositions and methods useful in promoting milk production

 #331
20200325221
2020-10-15

Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains

 #332
20200308244
2020-10-01

Therapeutic interferon alpha 1 proteins

 #333
20200299364
2020-09-24

Binding molecules directed against influenza hemagglutinin and uses thereof

 #334
20200291449
2020-09-17

METHODS AND COMPOSITIONS FOR DETECTING ANTI-DRUG ANTIBODIES

 #335
20200291128
2020-09-17

ANTIBODIES AND METHODS OF USE THEREOF

 #336
20200291127
2020-09-17

ANTIBODIES AND METHODS OF USE THEREOF

 #337
20200291108
2020-09-17

Polypeptides which bind to interleukin-6 receptor (IL-6R)

 #338
20200289646
2020-09-17

Mesothelin binding proteins

 #339
20200284800
2020-09-10

Identification and monitoring of immunoglobulin J chains

 #340
20200283729
2020-09-10

TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTOR

 #341
20200283509
2020-09-10

Serum albumin binders

 #342
20200283507
2020-09-10

Single-domain VH antibodies directed to norovirus GI.1 and GII.4 and their use

 #343
20200251186
2020-08-06

SYSTEMS AND METHODS FOR USING BEHAVIOR DATA OF IMPURITIES AND TARGET PROTEINS TO DESIGN DOWNSTREAM PROCESSES

 #344
20200239534
2020-07-30

Binding domains directed against GPCR:G protein complexes and uses derived thereof

 #345
20200231674
2020-07-23

CD8 binding agents

 #346
20200231662
2020-07-23

Immunoglobulin variable domains

 #347
20200231659
2020-07-23

Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)

 #348
20200216532
2020-07-09

Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains

 #349
20200216528
2020-07-09

Anti-IL-22R antibodies

 #350
20200200751
2020-06-25

Compositions and methods for detecting prostate cancer

 #351
20200199222
2020-06-25

Biparatopic polypeptides antagonizing Wnt signaling in tumor cells

 #352
20200199206
2020-06-25

BACTERIAL TOXIN-NEUTRALIZING NANOBODIES AND METHODS OF MAKING AND USING THE SAME

 #353
20200190216
2020-06-18

MMP13 binding immunoglobulins

 #354
20200190190
2020-06-18

Modified J-chain

 #355
20200181276
2020-06-11

Anti-GARP protein

 #356
20200165329
2020-05-28

Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof

 #357
20200165323
2020-05-28

Antibody capable of binding to influenza virus intranuclear protein, complex, detection apparatus and detection method using same

 #358
20200157248
2020-05-21

Asymmetric multispecific antibodies

 #359
20200157220
2020-05-21

CTLA4 binders

 #360
20200157216
2020-05-21

T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta

 #361
20200157207
2020-05-21

Anti-IL-22R antibodies

 #362
20200148790
2020-05-14

Glycosylation of variable immunoglobulin domains

 #363
20200148737
2020-05-14

Therapeutic compounds and methods

 #364
20200140532
2020-05-07

AGGRECAN BINDING IMMUNOGLOBULINS

 #365
20200123233
2020-04-23

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

 #366
20200103410
2020-04-02

Compositions and methods for detecting lung cancer

 #367
20200102374
2020-04-02

Immunoglobulin single variable domain antibody against RSV prefusion F protein

 #368
20200095311
2020-03-26

GARP-TGF-β 1 IGG antibodies

 #369
20200087411
2020-03-19

Targeted chimeric proteins and uses thereof

 #370
20200087404
2020-03-19

Method of screening for anti-GARP antibodies

 #371
20200079844
2020-03-12

Nanobodies against tumor necrosis factor-alpha

 #372
20200078399
2020-03-12

Chimeric antigen receptors targeting BCMA and methods of use thereof

 #373
20200071716
2020-03-05

Immunomodulating transgenic plants and related methods

 #374
20200071414
2020-03-05

Targeted engineered interferon and uses thereof

 #375
20200062833
2020-02-27

VHH-CONTAINING HEAVY CHAIN ANTIBODY AND PRODUCTION THEREOF

 #376
20200040067
2020-02-06

ANTI-SALMONELLA ANTIBODIES AND USES THEREOF

 #377
20200031952
2020-01-30

Method for treatment of an IL-17A-mediated disease through antibody administration specific to human IL-17A

 #378
20200025773
2020-01-23

Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof

 #379
20200024365
2020-01-23

mRNA-ENCODED NANOBODY AND APPLICATION THEREOF

 #380
20200024354
2020-01-23

BAFF selective binding compounds and related methods

 #381
20200024331
2020-01-23

Single domain antibodies to Chikungunya virus

 #382
20200010569
2020-01-09

Bispecific binding molecules binding to VEGF and Ang2

 #383
20190391159
2019-12-26

Compositions and methods for rapid production of versatile nanobody repertoires

 #384
20190383829
2019-12-19

PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF

 #385
20190383828
2019-12-19

Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof

 #386
20190383826
2019-12-19

PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF

 #387
20190383825
2019-12-19

PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF

 #388
20190375832
2019-12-12

Nucleic acids encoding GARP-TGF-beta 1 antibodies

 #389
20190367604
2019-12-05

Bispecific signaling agents and uses thereof

 #390
20190367598
2019-12-05

Immunoglobulin single variable domain (ISVD) capable of binding to serum albumin

 #391
20190367597
2019-12-05

Serum albumin binders

 #392
20190367596
2019-12-05

Serum albumin binding immunoglobulin single variable domains

 #393
20190359721
2019-11-28

Antigen-binding domain, and polypeptide including conveying section

 #394
20190359693
2019-11-28

Binding molecules directed against influenza hemagglutinin and uses thereof

 #395
20190352406
2019-11-21

Clec9A binding agents

 #396
20190352381
2019-11-21

Monovalent anti-properdin antibodies and antibody fragments

 #397
20190352379
2019-11-21

Agrochemical compositions comprising antibodies binding to sphingolipids

 #398
20190338025
2019-11-07

PD1 and/or LAG3 binders

 #399
20190338024
2019-11-07

Opioid receptor binding agents and uses thereof

 #400
20190330370
2019-10-31

Compositions and methods for increasing protein half-life in a serum

 #401
20190330340
2019-10-31

PD1 and/or LAG3 binders

 #402
20190330339
2019-10-31

PD1 and/or LAG3 binders

 #403
20190322753
2019-10-24

CX3CR1-binding polypeptides comprising immunoglobulin single variable domains

 #404
20190321453
2019-10-24

UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES

 #405
20190315873
2019-10-17

Anti-MET antibodies and uses thereof

 #406
20190314503
2019-10-17

Single domain antibodies directed against arachidonate 12-lipoxygenase

 #407
20190309083
2019-10-10

Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms

 #408
20190309056
2019-10-10

Immunoglobulin single variable domains directed against macrophage migration inhibitory factor

 #409
20190276819
2019-09-12

Protein screening and detection method

 #410
20190276551
2019-09-12

Antigen-binding polypeptides directed against CD38

 #411
20190270823
2019-09-05

Antibodies to CD70

 #412
20190270815
2019-09-05

Anti-PD-1 antibodies

 #413
20190263908
2019-08-29

Immunoglobulins binding human Vγ9Vδ2 T cell receptors

 #414
20190263898
2019-08-29

Anti-tau nanobodies

 #415
20190241668
2019-08-08

CD70 combination therapy

 #416
20190241653
2019-08-08

Humanized antibodies transmigrating the blood-brain barrier and uses thereof

 #417
20190241648
2019-08-08

Anti-ApoC3 antibodies and methods of use thereof

 #418
20190233519
2019-08-01

Single-domain antibodies and variants thereof against CTLA-4

 #419
20190233509
2019-08-01

IL-6 binding molecules

 #420
20190225693
2019-07-25

Nanobody based imaging and targeting of ECM in disease and development

 #421
20190225675
2019-07-25

Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein

 #422
20190218310
2019-07-18

Bispecific antigen binding construct

 #423
20190218290
2019-07-18

CAMEL DERIVED POLYPEPTIDES BINDING HUMAN CD3, IDENTIFIED USING A NOVEL ONE-STEP METHOD

 #424
20190218285
2019-07-18

Long-Acting Therapeutic Fusion Proteins

 #425
20190211101
2019-07-11

Amino acid sequences that modulate the interaction between cells of the immune system

 #426
20190202932
2019-07-04

ANTI- EGFR CONFORMATIONAL SINGLE DOMAIN ANTIBODIES AND USES THEREOF

 #427
20190185581
2019-06-20

Inhibitory antibodies against MMP-14

 #428
20190177437
2019-06-13

Single domain antibodies directed against intracellular antigens

 #429
20190177434
2019-06-13

SINGLE-DOMAIN ANTIGEN-BINDING PROTEINS THAT BIND MAMMALIAN IGG

 #430
20190169601
2019-06-06

RECOGNITION TAGS FOR TGASE-MEDIATED CONJUGATION

 #431
20190135930
2019-05-09

B cell maturation antigen binding proteins

 #432
20190127459
2019-05-02

Anti-IL-22R antibodies

 #433
20190119393
2019-04-25

Method for treating rheumatoid arthritis by administering IL-6 receptor antibodies

 #434
20190112392
2019-04-18

T cell recruiting polypeptides based on TCR alpha/beta reactivity

 #435
20190112363
2019-04-18

Polypeptides and polypeptide constructs comprising single domain antibodies directed against von willebrand factor

 #436
20190106498
2019-04-11

TREATMENT FOR ACUTE MYELOID LEUKEMIA

 #437
20190100599
2019-04-04

Nanobody dimers linked via C-terminally engineered cysteins

 #438
20190100594
2019-04-04

Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acids

 #439
20190100584
2019-04-04

Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same

 #440
20190077853
2019-03-14

Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof

 #441
20190077847
2019-03-14

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

 #442
20190071500
2019-03-07

CD8 binding agents

 #443
20190049463
2019-02-14

Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof

 #444
20190041400
2019-02-07

PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF

 #445
20190040119
2019-02-07

Method for producing antibody

 #446
20190023806
2019-01-24

CAMELID HEMOGLOBIN ANTIBODIES AND METHODS OF USE

 #447
20190023796
2019-01-24

Biological materials related to HER3

 #448
20190023795
2019-01-24

Fusion proteins targeting tumour associated macrophages for treating cancer

 #449
20190023793
2019-01-24

Anti-PD-L1 nanobody and use thereof

 #450
20190016811
2019-01-17

Antibody against a complex between human GARP and latent TGF-β

 #451
20190010249
2019-01-10

STABLE FORMULATIONS OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

 #452
20190002566
2019-01-03

Modified J-chain

 #453
20190002544
2019-01-03

Blood-brain barrier permeable peptide compositions comprising a VAB domain of an anti-amyloid-beta camelid single-domain heavy-chain only antibody

 #454
20180362656
2018-12-20

Single variable domain antibodies against OX40L, constructs and therapeutic use

 #455
20180362653
2018-12-20

Single chain fusionconstructs comprising multimeric antibody fragments fused to collagen trimerization domains

 #456
20180362617
2018-12-20

Antigen binding dimer-complexes, methods of making/avoiding and uses thereof

 #457
20180355050
2018-12-13

Polypeptides inhibiting CD40L

 #458
20180355048
2018-12-13

BIOLOGICAL MATERIALS RELATED TO CXCR7

 #459
20180355031
2018-12-13

TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

 #460
20180355011
2018-12-13

Binding-triggered transcriptional switches and methods of use thereof

 #461
20180353605
2018-12-13

Ferritin nanoparticle compositions and methods to modulate cell activity

 #462
20180353604
2018-12-13

FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES

 #463
20180346559
2018-12-06

Anti-cancer combination therapy

 #464
20180344868
2018-12-06

Polypeptides antagonizing Wnt signaling in tumor cells

 #465
20180334489
2018-11-22

TARGETING OF CYTOKINE ANTAGONISTS

 #466
20180334488
2018-11-22

Targeting of human interferon antagonists

 #467
20180333465
2018-11-22

Targeted and mutated human-interferon fusion proteins

 #468
20180327499
2018-11-15

ANTI- NKG2D SINGLE DOMAIN ANTIBODIES AND USES THEREOF

 #469
20180327491
2018-11-15

P2X7 receptor binders and polypeptides comprising the same

 #470
20180327487
2018-11-15

GARP-TGF-beta 1 antibodies

 #471
20180327481
2018-11-15

Synthetic single domain antibody

 #472
20180319882
2018-11-08

PLEXIN D1 AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY

 #473
20180319872
2018-11-08

Yeast-based immunotherapy against clostridium difficile infection

 #474
20180319870
2018-11-08

Methods to create chemically-induced dimerizing protein systems for regulation of cellular events

 #475
20180318431
2018-11-08

Methods of treating an ocular disease or disorder

 #476
20180312583
2018-11-01

Polypeptides against IL-23

 #477
20180305461
2018-10-25

Antigen-Binding Protein Directed Against Epitope in the CH1 Domain of Human IgG Antibodies

 #478
20180292408
2018-10-11

CAMELID SINGLE-DOMAIN HCV ANTIBODIES AND METHODS OF USE

 #479
20180282386
2018-10-04

Therapeutic compounds and methods

 #480
20180280551
2018-10-04

Labeling of antibodies

 #481
20180251529
2018-09-06

Composite comprising antibody capable of binding to intranuclear protein of influenza virus

 #482
20180251528
2018-09-06

Composite comprising antibody capable of binding to intranuclear protein of influenza virus

 #483
20180251527
2018-09-06

Single domain VHH antibodies directed to norovirus GI.1 and GII.4 and their use

 #484
20180244784
2018-08-30

VEGFR2 ANTIBODIES

 #485
20180244769
2018-08-30

P2X7 receptor antagonists and agonists

 #486
20180244765
2018-08-30

Methods of making heavy chain only antibodies using transgenic animals

 #487
20180238902
2018-08-23

METHODS FOR USING ANTIBODIES AND ANALOGS THEREOF

 #488
20180237507
2018-08-23

Single chain antibody domains for detection of anti-botulinum neurotoxin domains and methods of their use

 #489
20180230457
2018-08-16

Library-based methods and compositions for introducing molecular switch functionality into protein affinity reagents

 #490
20180230232
2018-08-16

Single domain antibodies capable of modulating BACE activity

 #491
20180230225
2018-08-16

Chimeric antigen receptors based on single domain antibodies and methods of use thereof

 #492
20180230219
2018-08-16

VEGFR-2 car immune cells to treat cancers

 #493
20180222978
2018-08-09

MUSCARINIC ACETYLCHOLINE RECEPTOR BINDING AGENTS AND USES THEREOF

 #494
20180222966
2018-08-09

TRANSGENIC PLANT COMPRISING A POLYNUCLEOTIDE ENCODING A VARIABLE DOMAIN OF HEAVY-CHAIN ANTIBODY

 #495
20180215833
2018-08-02

Anti c-Met antibodies

 #496
20180208644
2018-07-26

Anti-semaphorin 3A antibody and treatment of Alzheimer's disease and inflammatory immune diseases using same

 #497
20180208636
2018-07-26

Binding-triggered transcriptional switches and methods of use thereof

 #498
20180201671
2018-07-19

VEGF-BINDING MOLECULES

 #499
20180200393
2018-07-19

Radiolabelled antibody fragments for use in treating cancer

 #500
20180186894
2018-07-05

TARGETED MODIFIED IL-1 FAMILY MEMBERS

 #501
20180179551
2018-06-28

Transgenic plants expressing a variable domain of a heavy chain antibody (VHH) that binds to a sphingolipid of a fungus

 #502
20180179266
2018-06-28

Immunoglobulin single variable domain antibody against RSV prefusion F protein

 #503
20180169228
2018-06-21

Anti-VEGF antibody

 #504
20180162932
2018-06-14

Antibodies binding to BMP4, and uses thereof

 #505
20180142000
2018-05-24

Anti-campylobacter jejuni antibodies and uses therefor

 #506
20180134769
2018-05-17

CLOSTRIDIUM DIFFICILE-SPECIFIC ANTIBODIES AND USES THEREOF

 #507
20180118818
2018-05-03

Sensor systems for target ligands and uses thereof

 #508
20180105582
2018-04-19

Therapeutic composition of camel milk

 #509
20180105581
2018-04-19

Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections

 #510
20180100865
2018-04-12

Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof

 #511
20180100017
2018-04-12

Anti-FLT-1 antibodies in treating bronchopulmonary dysplasia

 #512
20180100009
2018-04-12

POLYPEPTIDE COMPRISING AN IMMUNOGLOBULIN CHAIN VARIABLE DOMAIN WHICH BINDS TO CLOSTRIDIUM DIFFICILE TOXIN A

 #513
20180079812
2018-03-22

Binding-triggered transcriptional switches and methods of use thereof

 #514
20180078632
2018-03-22

VHH constructs for diverting an immune response

 #515
20180072806
2018-03-15

Anti-Flt-1 antibodies for treating duchenne muscular dystrophy

 #516
20180067126
2018-03-08

Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof

 #517
20180057605
2018-03-01

Blood brain barrier transport molecules and uses thereof

 #518
20180057555
2018-03-01

Targeting of human interferon antagonists

 #519
20180044424
2018-02-15

Car-expressing cells against multiple tumor antigens and uses thereof

 #520
20180030141
2018-02-01

CX3CR1-binding polypeptides comprising immunoglobulin single variable domains

 #521
20180030120
2018-02-01

Anti-salmonella antibodies and uses thereof

 #522
20180030117
2018-02-01

Synthetic single domain antibody

 #523
20180028616
2018-02-01

Targeted human-interferon fusion proteins

 #524
20180022811
2018-01-25

Chemokine receptor binding polypeptides

 #525
20180022794
2018-01-25

Anti-Rho GTPase conformational single domain antibodies and uses thereof

 #526
20180022791
2018-01-25

Agrochemical compositions comprising antibodies binding to sphingolipids

 #527
20180016351
2018-01-18

ANTIBODIES COMPRISING SEQUENCES FROM CAMELIDAE TO HIGHLY CONSERVED TARGETS

 #528
20180016342
2018-01-18

Methods for the treatment of interleukin-6 receptor-related diseases and disorders

 #529
20180016337
2018-01-18

CEACAM6 CAR immune cells to treat cancers

 #530
20180016323
2018-01-18

Binding molecules directed against influenza hemagglutinin and uses thereof

 #531
20180009888
2018-01-11

TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

 #532
20180002445
2018-01-04

Antigen-binding constructs that bind to and inhibit catalase and/or superoxide dismutase as well as pharmaceutical compositions containing them for tumor therapy

 #533
20180002439
2018-01-04

ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF

 #534
20180000963
2018-01-04

Antibody-urease conjugates for therapeutic purposes

 #535
20170369868
2017-12-28

METHOD FOR ENGINEERING IMMUNOGLOBULINS

 #536
20170369581
2017-12-28

Antibodies to CD70

 #537
20170369527
2017-12-28

METHOD FOR AFFINITY PURIFICATION

 #538
20170360955
2017-12-21

Cysteine linked nanobody dimers

 #539
20170349667
2017-12-07

C-MET ANTIBODY COMBINATIONS

 #540
20170342166
2017-11-30

Asymmetric multispecific antibodies

 #541
20170342146
2017-11-30

NANOBODIES AGAINST TUMOR NECROSIS FACTOR-ALPHA

 #542
20170334983
2017-11-23

Sequences directed against hepatocyte growth factor (HGF) and polypeptides comprising the same for the treatment of cancers and/or tumors

 #543
20170334958
2017-11-23

PROTEIN SCAFFOLDS FOR ANTIBODY MIMICS AND OTHER BINDING PROTEINS

 #544
20170327586
2017-11-16

Synergistic combinations of OX40L antibodies for the treatment of GvHD

 #545
20170283510
2017-10-05

Modified J-chain

 #546
20170283490
2017-10-05

Nanobodies suitable for neuron regeneration therapy

 #547
20170283485
2017-10-05

Antibody capable of binding to influenza virus

 #548
20170281737
2017-10-05

UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES

 #549
20170275361
2017-09-28

Serum albumin binding proteins containing immunoglobulin single variable domains

 #550
20170275360
2017-09-28

Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains

 #551
20170275342
2017-09-28

PROTEIN SCAFFOLDS FOR ANTIBODY MIMICS AND OTHER BINDING PROTEINS

 #552
20170274013
2017-09-28

WOUND FLUID ELEVATED PROTEASE ENZYME INHIBITION THROUGH CAMELID BLOOD PRODUCTS

 #553
20170267755
2017-09-21

ISOLATED ANTI-MESOTHELIN ANTIBODIES, CONJUGATES AND USES THEREOF

 #554
20170266276
2017-09-21

Combination Therapy For Treatment of Cancer

 #555
20170260279
2017-09-14

Synergistic combinations of OX40L antibodies for the treatment of GvHD

 #556
20170253652
2017-09-07

INHIBITION OF BONE RESORPTION WITH RANKL BINDING PEPTIDES

 #557
20170253644
2017-09-07

Binding domains directed against GPCR:G protein complexes and uses derived thereof

 #558
20170247475
2017-08-31

Bispecific binding molecules binding to VEGF and Ang2

 #559
20170247434
2017-08-31

Norovirus antibodies

 #560
20170226566
2017-08-10

Method and system for screening nanobody

 #561
20170212130
2017-07-27

COMPOSITIONS AND METHODS FOR RAPID PRODUCTION OF VERSATILE NANOBODY REPERTOIRES

 #562
20170190787
2017-07-06

Anti-EGFR conformational single domain antibodies and uses thereof

 #563
20170183645
2017-06-29

COMPOSITION AND METHOD FOR DIVERSIFYING POLYPEPTIDE LIBRARIES

 #564
20170183409
2017-06-29

Modified J-chain

 #565
20170183404
2017-06-29

Opioid receptor binding agents and uses thereof

 #566
20170174762
2017-06-22

Biparatopic polypeptides antagonizing Wnt signaling in tumor cells

 #567
20170166647
2017-06-15

Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders

 #568
20170165383
2017-06-15

Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins

 #569
20170158760
2017-06-08

Isolation and Purification of Antibodies Using Protein A Affinity Chromatography

 #570
20170153245
2017-06-01

Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof

 #571
20170152324
2017-06-01

Antigen binding formats for use in therapeutic treatments or diagnostic assays

 #572
20170152305
2017-06-01

Expression of a single chain antibody against in

#573
20170145098
2017-05-25

Anti-mGluR2 conformational single domain antibodies and uses thereof

 #574
20170137521
2017-05-18

CTLA4 binders

 #575
20170137517
2017-05-18

PD1 and/or LAG3 binders

 #576
20170137512
2017-05-18

KV1.3 binding immunoglobulins

 #577
20170122941
2017-05-04

Screening of protein candidates

 #578
20170121399
2017-05-04

Immunoglobulin variable domains

 #579
20170121395
2017-05-04

Single domain antibodies directed against human immunodeficiency virus

 #580
20170121392
2017-05-04

Single domain antibodies directed against ebola virus VP24

 #581
20170081411
2017-03-23

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

 #582
20170081401
2017-03-23

Anti-IL-17 antibodies

 #583
20170072020
2017-03-16

Targeted human-interferon fusion proteins

 #584
20170066843
2017-03-09

Anti-IL-17A Antibodies

 #585
20170058022
2017-03-02

Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof

 #586
20170044269
2017-02-16

ADENOVIRAL TARGETING, COMPOSITIONS AND METHODS THEREFOR

 #587
20170044242
2017-02-16

Lung-targeting nanobodies against pulmonary surfactant protein A and their preparation

 #588
20170037137
2017-02-09

SYNERGISTIC COMBINATIONS OF OX40L ANTIBODIES FOR THE TREATMENT OF GVHD

 #589
20170029506
2017-02-02

Immunoglobulins binding human Vγ9 Vδ2 T cell receptors

 #590
20170029505
2017-02-02

MULTIMERIC FC PROTEINS

 #591
20170022284
2017-01-26

Multispecific GITR-binding fusion proteins and methods of use thereof

 #592
20170022277
2017-01-26

Insulin-like growth factor 1 receptor-specific antibodies and uses thereof

 #593
20170015753
2017-01-19

Multivalent and multispecific DR5-binding fusion proteins

 #594
20170015749
2017-01-19

Insulin-like growth factor 1 receptor-specific antibodies and uses thereof

 #595
20170015748
2017-01-19

Insulin-like growth factor 1 receptor-specific antibodies and uses thereof

 #596
20170002069
2017-01-05

Polypeptides

 #597
20170002065
2017-01-05

Use of VHH antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications

 #598
20160368978
2016-12-22

Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis

 #599
20160368972
2016-12-22

Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein

 #600
20160355595
2016-12-08

CX3CR1-binding polypeptides